About
TIUM BIO is a South Korean biopharmaceutical company developing synthetic and biologic drug candidates targeting rare and intractable diseases including immuno-oncology, fibrotic diseases, endometriosis, and hemophilia.
Explore TIUM BIO's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.